A new study published in The New England Journal of Medicine showed that for high-risk patients with pulmonary arterial ...

Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension (PPH). Recently, fenfluramine appetite suppressants became widely ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.

We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...

When considering whether a child who has a single-ventricle heart defect would benefit more from biventricular repair or the ...

We recently published a list of 11 Best Quality Penny Stocks to Buy According to Hedge Funds. In this article, we are going ...

preeclampsia or pregnancy-induced hypertension with a PRERISK score <5%; outpatient follow-up with a PRERISK score ≥5%, birth >7 days after the last PRERISK measurement, or no prepartum PRERISK ...

The following is a summary of “Right atrial reservoir strain as an early predictor of pulmonary hypertension development in ...

To assess how a patient with pulmonary arterial hypertension (PAH) is faring on therapy, look at the right heart, said Anjali ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.